Sorrento Therapeutics Investor
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Funding Status:
IPO
Industry:
PharmTech
Estimated Revenue:
$1M to $10M
Technology:
Others
Acquisitions Number:
Made Acquisitions
Number Of Exists:
N/A
Headquarters:
San Diego, California, United States
Total Funding:
264418495.0
Last Funding Date:
2019-10-09
Last Funding Type:
Post-IPO Equity
Investor Type:
N/A
Employee Number:
101-250
Investors Number:
1
Investment Stage:
N/A
Founded Date:
2006-01-01